Cancer Biomarker Market Size to Hit USD 27.8 Billion by 2030 at 9.8% CAGR – Report by Market Research Future (MRFR)
15 juin 2023 05h25 HE
|
Market Research Future
New York, USA, June 15, 2023 (GLOBE NEWSWIRE) -- Cancer Biomarker Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Cancer Biomarker Market Information...
Purple Biotech Reports Biomarker Data from CM24 Phase 1 Dose Escalation Study
16 mars 2023 07h00 HE
|
Purple Biotech Ltd.
Reduction in neutrophil extracellular traps (NETs) markersPotential association between patient survival and CEACAM1 positive lymphocytes REHOVOT, Israel, March 16, 2023 (GLOBE NEWSWIRE) -- ...
Metabolomics Services Market to Surpass US$ 1,396.79 Million by 2030, Says Coherent Market Insights (CMI)
10 févr. 2023 09h00 HE
|
CMI
Burlingame, Feb. 10, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global metabolomics services market is estimated to be valued at US$ 483.74 in 2022 and is expected to...
Cancer Biomarker Market was valued USD 12 billion in 2021 & it will grow at a CAGR of 18% till 2029 : GreyViews
15 déc. 2022 11h00 HE
|
GreyViews
Pune India, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East...
Vocal Biomarkers Market Size Worth USD 1.91 Billion by 2030 at 17.50% CAGR – Report by Market Research Future (MRFR)
01 déc. 2022 10h00 HE
|
Market Research Future
New York, USA, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Vocal Biomarkers Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Vocal Biomarkers Market...
Next Generation Cancer Diagnostics Market Size to Garner $29.7 billion by 2028 with 17.80% CAGR: Latest Industry Insight by Markets N Research
10 nov. 2022 09h00 HE
|
Markets N Research
Chicago, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The report "Next Generation Cancer Diagnostics Market by Technology (NGS, LOAC, RT-PCR) Application (CTC, Biomarker), Cancer Type (Lung, Breast) – Global...
Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in the journal Nature
10 juin 2021 02h00 HE
|
Nucleome Therapeutics
Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in the journal Nature New method is being used by Nucleome to unlock the...
Nucleome Therapeutics announces appointment of Dr Jonathan Hepple as a Non-Executive Director to its Board
25 mai 2021 02h00 HE
|
Nucleome Therapeutics
Nucleome Therapeutics announces appointment of Dr Jonathan Hepple as a Non-Executive Director to its Board Nucleome’s unique technology platform has the potential to discover precision therapeutics...
Allarity Therapeutics To Present a Dovitinib-DRP® e-Poster at the European Association for Cancer Research (EACR) 2021 Virtual Congress
29 avr. 2021 10h31 HE
|
Allarity Therapeutics A/S
- Poster title: A novel drug response predictor (DRP®) mRNA biomarker for the multi tyrosine kinase inhibitor dovitinib - Poster provides new details of the DRP® companion diagnostic for dovitinib,...
Fluidigm Announces Fourth Quarter and Full Year 2020 Financial Results
10 févr. 2021 16h05 HE
|
Fluidigm Corporation
Fourth Quarter Total Revenue Increased 38 Percent to $44.6 million Fourth Quarter Product and Service Revenue Increased 26 Percent to $40.5 million Full Year Total Revenue Increased 18 Percent to...